Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Oncology Topic Center

Featured

Headshot of Scott Tomlins, Strata Oncology, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Comprehensive Genomic Profiling With Less Tissue Expands Treatment Guidance
02/18/2022
Maria Asimopoulos
Scott Tomlins, MD, PhD, cofounder and chief medical officer, Strata Oncology, discusses how a test that requires less tissue can provide genomic profiling for patients with cancer whose tissue sample is limited for testing to guide treatment...
Scott Tomlins, MD, PhD, cofounder and chief medical officer, Strata Oncology, discusses how a test that requires less tissue can provide genomic profiling for patients with cancer whose tissue sample is limited for testing to guide treatment...
Scott Tomlins, MD, PhD,...
02/18/2022
Population Health
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
Reviewing the Benefits of a Treatment for Patients With Acute Myeloid Leukemia
08/09/2021
Julie Gould
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health
News
FDA Approves Monoclonal Antibody for Use in Combination Treatment for Multiple Myeloma
07/13/2021
Maria Asimopoulos
"With this approval, we are now able to combine pomalidomide and dexamethasone with a daratumumab subcutaneous option that can be administered in minutes rather than the hours needed for intravenous administration,” said Meletios A...
"With this approval, we are now able to combine pomalidomide and dexamethasone with a daratumumab subcutaneous option that can be administered in minutes rather than the hours needed for intravenous administration,” said Meletios A...
"With this approval, we are now...
07/13/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Headshot of Dr Efstathios Kastritis on a blue background underneath the PopHealth Perspectives logo.
Videos
Treatment Efficacy of Daratumumab in Newly Diagnosed AL Amyloidosis
07/12/2021
Maria Asimopoulos
Efstathios Kastritis, MD, associate professor of clinical therapeutics/medical oncology, National and Kapodistrian University of Athens, School of Medicine, discusses the findings of the ANDROMEDA study, a phase 3 clinical study that...
Efstathios Kastritis, MD, associate professor of clinical therapeutics/medical oncology, National and Kapodistrian University of Athens, School of Medicine, discusses the findings of the ANDROMEDA study, a phase 3 clinical study that...
Efstathios Kastritis, MD,...
07/12/2021
Population Health
Debatable Topics in Oncology Pharmacy: New Meeting to Offer Insight for Pharmacists
Podcasts
Debatable Topics in Oncology Pharmacy: New Meeting to Offer Insight for Pharmacists
05/17/2021
Chris Fausel, PharmD, MHA, BCOP, clinical manager, oncology pharmacy, Indiana University Health, and co-chair of the new Great Debates & Updates in Oncology Pharmacy, discusses this new program for pharmacists that highlights 15 topics,...
Chris Fausel, PharmD, MHA, BCOP, clinical manager, oncology pharmacy, Indiana University Health, and co-chair of the new Great Debates & Updates in Oncology Pharmacy, discusses this new program for pharmacists that highlights 15 topics,...
Chris Fausel, PharmD, MHA, BCOP,...
05/17/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Congress Must Expand Cancer Treatment Options for America’s Veterans
Commentary
Congress Must Expand Cancer Treatment Options for America’s Veterans
04/27/2021
Victor Murray, Air Force veteran and prostate cancer survivor, explains why he urges Congress to work more with the VA to expand access to high-intensity focused ultrasound and focused ultrasound therapy for America’s veterans.
Victor Murray, Air Force veteran and prostate cancer survivor, explains why he urges Congress to work more with the VA to expand access to high-intensity focused ultrasound and focused ultrasound therapy for America’s veterans.
Victor Murray, Air Force veteran...
04/27/2021
Veterans Health Today
From Veterans Health Today
The Ideal Elective Surgery During a Pandemic
Commentary
The Ideal Elective Surgery During a Pandemic
02/18/2021
This article explains how David Silver, MD, chief of urology and director of the Prostate Center at Maimonides Medical Center, changed his treatment decisions amid the pandemic, and highlights the use of the new CPT code for high intensity...
This article explains how David Silver, MD, chief of urology and director of the Prostate Center at Maimonides Medical Center, changed his treatment decisions amid the pandemic, and highlights the use of the new CPT code for high intensity...
This article explains how David...
02/18/2021
Population Health
Reviewing the Recent FDA Approval of Venclexta for AML
Interview
Reviewing the Recent FDA Approval of Venclexta for AML
02/04/2021
Tony Lin, PharmD, senior scientific director, AbbVie US medical affairs, discusses the VIALE-A and VIALE-C trials, which helped determine the approval of Venclexta for acute myeloid leukemia, and highlights what this approval means for...
Tony Lin, PharmD, senior scientific director, AbbVie US medical affairs, discusses the VIALE-A and VIALE-C trials, which helped determine the approval of Venclexta for acute myeloid leukemia, and highlights what this approval means for...
Tony Lin, PharmD, senior...
02/04/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Using Minimal Residual Disease to Improve Treatment Outcomes Among Patients With Cancer
Interview
Using Minimal Residual Disease to Improve Treatment Outcomes Among Patients With Cancer
01/14/2021
“With more specific and accurate information about a patient’s disease status or how that patient is responding to treatment, doctors can have more robust conversations with their patients about treatment goals, treatment effectiveness, and...
“With more specific and accurate information about a patient’s disease status or how that patient is responding to treatment, doctors can have more robust conversations with their patients about treatment goals, treatment effectiveness, and...
“With more specific and accurate...
01/14/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Study Supports the Need for Real-World Evidence to Better Manage CLL Patients
Videos
Study Supports the Need for Real-World Evidence to Better Manage CLL Patients
12/09/2020
Anthony Mato, MD, Memorial Sloan Kettering Cancer Center, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with chronic lymphocytic leukemia (CLL) in the clinical practice setting, using the informCLL...
Anthony Mato, MD, Memorial Sloan Kettering Cancer Center, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with chronic lymphocytic leukemia (CLL) in the clinical practice setting, using the informCLL...
Anthony Mato, MD, Memorial Sloan...
12/09/2020
Population Health
Benefits of Dual Treatment for MCL
Videos
Benefits of Dual Treatment for MCL
12/09/2020
Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.
Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.
Constantine Tam, MD, director of...
12/09/2020
Population Health

Newsfeed

News
FDA Approves Monoclonal Antibody for Use in Combination Treatment for Multiple Myeloma
07/13/2021
Maria Asimopoulos
"With this approval, we are now able to combine pomalidomide and dexamethasone with a daratumumab subcutaneous option that can be administered in minutes rather than the hours needed for intravenous administration,” said Meletios A...
"With this approval, we are now able to combine pomalidomide and dexamethasone with a daratumumab subcutaneous option that can be administered in minutes rather than the hours needed for intravenous administration,” said Meletios A...
"With this approval, we are now...
07/13/2021
Pharmacy Learning Network
News
Frailty a Factor in Urinary Diversion Choice for Patients With Bladder Cancer
06/01/2020
“Frailty is significantly associated with the type of urinary diversion,” they concluded, “and it should be considered for the selection of urinary diversion in muscle-invasive bladder cancer patients undergoing radical cystectomy.”
“Frailty is significantly associated with the type of urinary diversion,” they concluded, “and it should be considered for the selection of urinary diversion in muscle-invasive bladder cancer patients undergoing radical cystectomy.”
“Frailty is significantly...
06/01/2020
Annals of Long-Term Care
News
Immune System Alterations Occur Early on in the Development of Multiple Myeloma
05/19/2020
This study represents the first time that single-cell RNA sequencing has been employed to detect features of the immune microenvironment in myeloma precursor conditions.
This study represents the first time that single-cell RNA sequencing has been employed to detect features of the immune microenvironment in myeloma precursor conditions.
This study represents the first...
05/19/2020
Pharmacy Learning Network
News
Agent Orange Exposure Linked with Head and Neck Cancer in Veterans
05/15/2020
According to a study including over 8 million veterans, self-reported exposure to Agent Orange was significantly associated with an increased risk of head and neck cancer.
According to a study including over 8 million veterans, self-reported exposure to Agent Orange was significantly associated with an increased risk of head and neck cancer.
According to a study including...
05/15/2020
Veterans Health Today
News
Agent Orange Exposure Increases Risk of Progression to Multiple Myeloma
03/13/2020
“Monoclonal gammopathy is a premalignant condition with the risk of progressing to multiple myeloma. Exposure to Agent Orange has been implicated in multiple conditions including multiple myeloma,” researchers wrote.
“Monoclonal gammopathy is a premalignant condition with the risk of progressing to multiple myeloma. Exposure to Agent Orange has been implicated in multiple conditions including multiple myeloma,” researchers wrote.
“Monoclonal gammopathy is a...
03/13/2020
Veterans Health Today
News
Multidisciplinary Collaborative Approach Proves Beneficial for Oral Anticancer Med Adherence
02/13/2020
Researchers recently explained that a “pharmacist-led adherence program, combined with low-cost adherence tools, exceeded the goal for the adherence initiative, suggesting that a multidisciplinary collaborative approach to [oral anticancer...
Researchers recently explained that a “pharmacist-led adherence program, combined with low-cost adherence tools, exceeded the goal for the adherence initiative, suggesting that a multidisciplinary collaborative approach to [oral anticancer...
Researchers recently explained...
02/13/2020
Pharmacy Learning Network
News
Nonconforming Breast Cancer Treatment in Elderly Women May Not Worsen Outcomes
01/01/2020
Although outcomes are not negatively impacted, researchers recently examined older women with breast cancer, aged between 77 and 81 years, and found that many of them do not receive treatment that fully conforms to National Comprehensive...
Although outcomes are not negatively impacted, researchers recently examined older women with breast cancer, aged between 77 and 81 years, and found that many of them do not receive treatment that fully conforms to National Comprehensive...
Although outcomes are not...
01/01/2020
Annals of Long-Term Care
News
At-risk individuals need surveillance for familial pancreatic cancer
11/14/2019
Individuals who have multiple close relatives with pancreatic cancer should undergo surveillance for pancreatic cancer, according to updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
Individuals who have multiple close relatives with pancreatic cancer should undergo surveillance for pancreatic cancer, according to updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
Individuals who have multiple...
11/14/2019
Population Health
News
Omega-3s and Vitamin D: Are They Beneficial for CVD, Cancer Prevention?
09/24/2019
“The pattern of findings suggests a complex balance of benefits and risks for each intervention and points to the need for additional research to determine which individuals may be most likely to derive a net benefit from these supplements,”...
“The pattern of findings suggests a complex balance of benefits and risks for each intervention and points to the need for additional research to determine which individuals may be most likely to derive a net benefit from these supplements,”...
“The pattern of findings...
09/24/2019
Pharmacy Learning Network
News
Older Women Have More Complications From Mastectomy With Immediate Breast Reconstruction
08/29/2019
Immediate breast reconstruction (IBR) after mastectomy improves quality of life and body image, but only about one in six women aged 65 years and older diagnosed with breast cancer undergo mastectomy with IBR.
Immediate breast reconstruction (IBR) after mastectomy improves quality of life and body image, but only about one in six women aged 65 years and older diagnosed with breast cancer undergo mastectomy with IBR.
Immediate breast reconstruction...
08/29/2019
Annals of Long-Term Care
News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
Dean Celia
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care
News
PhRMA Maps Provide State-by-State Look at 340B Drug Program
04/05/2024
Paul Nicolaus
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024

Danielle Sposato

Danielle Sposato
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
News
Medicare Drug Price Negotiations and Anticipated Ripple Effects
02/15/2024
Paul Nicolaus
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023

Amanda Balbi

Amanda Balbi
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
Population Health
News
Low Rate of Social Determinants of Health Z Codes in Adults With Hypertension
06/26/2023
Jolynn Tumolo
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the...
06/26/2023
First Report Managed Care
News
CDC Data Shows Link Between High Costs and Prescription Nonadherence in Adults
06/21/2023
Julie Gould
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence...
06/21/2023
First Report Managed Care
News
Blood Pressure Injections Recalled
05/26/2023
Jolynn Tumolo
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
Jolynn Tumolo
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network

Advertisement

Insights

Headshot of Scott Tomlins, Strata Oncology, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Comprehensive Genomic Profiling With Less Tissue Expands Treatment Guidance
02/18/2022
Maria Asimopoulos
Scott Tomlins, MD, PhD, cofounder and chief medical officer, Strata Oncology, discusses how a test that requires less tissue can provide genomic profiling for patients with cancer whose tissue sample is limited for testing to guide treatment...
Scott Tomlins, MD, PhD, cofounder and chief medical officer, Strata Oncology, discusses how a test that requires less tissue can provide genomic profiling for patients with cancer whose tissue sample is limited for testing to guide treatment...
Scott Tomlins, MD, PhD,...
02/18/2022
Population Health
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
Reviewing the Benefits of a Treatment for Patients With Acute Myeloid Leukemia
08/09/2021
Julie Gould
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health
Headshot of Dr Efstathios Kastritis on a blue background underneath the PopHealth Perspectives logo.
Videos
Treatment Efficacy of Daratumumab in Newly Diagnosed AL Amyloidosis
07/12/2021
Maria Asimopoulos
Efstathios Kastritis, MD, associate professor of clinical therapeutics/medical oncology, National and Kapodistrian University of Athens, School of Medicine, discusses the findings of the ANDROMEDA study, a phase 3 clinical study that...
Efstathios Kastritis, MD, associate professor of clinical therapeutics/medical oncology, National and Kapodistrian University of Athens, School of Medicine, discusses the findings of the ANDROMEDA study, a phase 3 clinical study that...
Efstathios Kastritis, MD,...
07/12/2021
Population Health
Debatable Topics in Oncology Pharmacy: New Meeting to Offer Insight for Pharmacists
Podcasts
Debatable Topics in Oncology Pharmacy: New Meeting to Offer Insight for Pharmacists
05/17/2021
Chris Fausel, PharmD, MHA, BCOP, clinical manager, oncology pharmacy, Indiana University Health, and co-chair of the new Great Debates & Updates in Oncology Pharmacy, discusses this new program for pharmacists that highlights 15 topics,...
Chris Fausel, PharmD, MHA, BCOP, clinical manager, oncology pharmacy, Indiana University Health, and co-chair of the new Great Debates & Updates in Oncology Pharmacy, discusses this new program for pharmacists that highlights 15 topics,...
Chris Fausel, PharmD, MHA, BCOP,...
05/17/2021
Pharmacy Learning Network
Congress Must Expand Cancer Treatment Options for America’s Veterans
Commentary
Congress Must Expand Cancer Treatment Options for America’s Veterans
04/27/2021
Victor Murray, Air Force veteran and prostate cancer survivor, explains why he urges Congress to work more with the VA to expand access to high-intensity focused ultrasound and focused ultrasound therapy for America’s veterans.
Victor Murray, Air Force veteran and prostate cancer survivor, explains why he urges Congress to work more with the VA to expand access to high-intensity focused ultrasound and focused ultrasound therapy for America’s veterans.
Victor Murray, Air Force veteran...
04/27/2021
Veterans Health Today
The Ideal Elective Surgery During a Pandemic
Commentary
The Ideal Elective Surgery During a Pandemic
02/18/2021
This article explains how David Silver, MD, chief of urology and director of the Prostate Center at Maimonides Medical Center, changed his treatment decisions amid the pandemic, and highlights the use of the new CPT code for high intensity...
This article explains how David Silver, MD, chief of urology and director of the Prostate Center at Maimonides Medical Center, changed his treatment decisions amid the pandemic, and highlights the use of the new CPT code for high intensity...
This article explains how David...
02/18/2021
Population Health
Reviewing the Recent FDA Approval of Venclexta for AML
Interview
Reviewing the Recent FDA Approval of Venclexta for AML
02/04/2021
Tony Lin, PharmD, senior scientific director, AbbVie US medical affairs, discusses the VIALE-A and VIALE-C trials, which helped determine the approval of Venclexta for acute myeloid leukemia, and highlights what this approval means for...
Tony Lin, PharmD, senior scientific director, AbbVie US medical affairs, discusses the VIALE-A and VIALE-C trials, which helped determine the approval of Venclexta for acute myeloid leukemia, and highlights what this approval means for...
Tony Lin, PharmD, senior...
02/04/2021
Pharmacy Learning Network
Using Minimal Residual Disease to Improve Treatment Outcomes Among Patients With Cancer
Interview
Using Minimal Residual Disease to Improve Treatment Outcomes Among Patients With Cancer
01/14/2021
“With more specific and accurate information about a patient’s disease status or how that patient is responding to treatment, doctors can have more robust conversations with their patients about treatment goals, treatment effectiveness, and...
“With more specific and accurate information about a patient’s disease status or how that patient is responding to treatment, doctors can have more robust conversations with their patients about treatment goals, treatment effectiveness, and...
“With more specific and accurate...
01/14/2021
Pharmacy Learning Network
Study Supports the Need for Real-World Evidence to Better Manage CLL Patients
Videos
Study Supports the Need for Real-World Evidence to Better Manage CLL Patients
12/09/2020
Anthony Mato, MD, Memorial Sloan Kettering Cancer Center, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with chronic lymphocytic leukemia (CLL) in the clinical practice setting, using the informCLL...
Anthony Mato, MD, Memorial Sloan Kettering Cancer Center, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with chronic lymphocytic leukemia (CLL) in the clinical practice setting, using the informCLL...
Anthony Mato, MD, Memorial Sloan...
12/09/2020
Population Health
Benefits of Dual Treatment for MCL
Videos
Benefits of Dual Treatment for MCL
12/09/2020
Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.
Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.
Constantine Tam, MD, director of...
12/09/2020
Population Health

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

What's Trending?

News
Metformin Impact on Statin-Associated Muscle Pain
04/20/2018
Researchers examined the impact metformin had on non-severe muscle pain associated with statin use.
Researchers examined the impact metformin had on non-severe muscle pain associated with statin use.
Researchers examined the impact...
04/20/2018
Pharmacy Learning Network
Review
Management of Vulvovaginal Disorders in Older Women
04/13/2020
Rohani Manda, MD
Nader Tavakoli, MD, CMD, FAAFP
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD
Nkenna Odom, MD
Stacy Ross, MD
Tiffany Mapp, MD
The objective of this paper is to emphasize the common vulvovaginal problems, other than infections, in older women and their management.
The objective of this paper is to emphasize the common vulvovaginal problems, other than infections, in older women and their management.
The objective of this paper is...
04/13/2020
Annals of Long-Term Care
News
Eye Drops Recalled
06/16/2022
Jolynn Tumolo
A prescription medication used to treat signs and symptoms of dry eye disease is being voluntarily recalled by Novartis Pharmaceuticals Corporation.
A prescription medication used to treat signs and symptoms of dry eye disease is being voluntarily recalled by Novartis Pharmaceuticals Corporation.
A prescription medication used...
06/16/2022
Pharmacy Learning Network
Feature
Lower Gastrointestinal Bleeding in the Elderly
09/05/2008

Maxwell Chait, MD, FACP, FACG, AGAF

Maxwell Chait, MD, FACP, FACG, AGAF ...
Maxwell Chait, MD, FACP, FACG, AGAF, reviews lower gastrointestinal (GI) bleeding in older adults, a significant cause of increased morbidity and mortality in this population. 
Maxwell Chait, MD, FACP, FACG, AGAF, reviews lower gastrointestinal (GI) bleeding in older adults, a significant cause of increased morbidity and mortality in this population. 
Maxwell Chait, MD, FACP, FACG,...
09/05/2008
Annals of Long-Term Care
Newsfeed
Blood Pressure Drug Recalled
01/25/2019
The FDA is recalling a combination angiotensin II receptor antagonist and thiazide diuretic used to treat patients with hypertension.
The FDA is recalling a combination angiotensin II receptor antagonist and thiazide diuretic used to treat patients with hypertension.
The FDA is recalling a...
01/25/2019
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement